Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Bach

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Chemmedchem|March 9, 2023
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit GenerationJean Quancard, Anna Vulpetti, Anders Bach, et al.
Chemmedchem|April 7, 2021
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug DiscoveryJean Quancard, Anders Bach, Brian Cox, et al.
Journal of Medicinal Chemistry|February 10, 2022
Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput ScreeningSang-Woo Lee, Kim Tai Tran, Ruben Vazquez-Uribe, et al.
Journal of Medicinal Chemistry|January 11, 2020
Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug DiscoverySara Marie Øie Solbak, Jie Zang, Dilip Narayanan, et al.
Chembiochem : a European Journal of Chemical Biology|February 28, 2026
Identification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational ModellingNadine E M Myers, Joanna Whittaker, Marie Elodie Hélène Cadot, et al.
Plos One|May 22, 2013
PDZ domain-mediated interactions of G protein-coupled receptors with postsynaptic density protein 95: quantitative characterization of interactionsThor C Møller, Volker F Wirth, Nina I Roberts, et al.
Journal of the American Chemical Society|December 2, 2011
Side-chain interactions form late and cooperatively in the binding reaction between disordered peptides and PDZ domainsS Raza Haq, Celestine N Chi, Anders Bach, et al.
Journal of Medicinal Chemistry|August 15, 2019
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular ActivityKim T Tran, Jakob S Pallesen, Sara M Ø Solbak, et al.
Organic & Biomolecular Chemistry|July 30, 2010
Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1Anders Bach, Nicolai Stuhr-Hansen, Thor S Thorsen, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Chemmedchem|March 9, 2023
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit GenerationJean Quancard, Anna Vulpetti, Anders Bach, et al.
Chemmedchem|April 7, 2021
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug DiscoveryJean Quancard, Anders Bach, Brian Cox, et al.
Journal of Medicinal Chemistry|February 10, 2022
Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput ScreeningSang-Woo Lee, Kim Tai Tran, Ruben Vazquez-Uribe, et al.
Journal of Medicinal Chemistry|January 11, 2020
Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug DiscoverySara Marie Øie Solbak, Jie Zang, Dilip Narayanan, et al.
Chembiochem : a European Journal of Chemical Biology|February 28, 2026
Identification of ZFTA as a Novel KLHL20 Substrate and Mechanistic Insights Into Fuzzy Binding of Disordered Peptides via Biosensor Analysis and Computational ModellingNadine E M Myers, Joanna Whittaker, Marie Elodie Hélène Cadot, et al.
Plos One|May 22, 2013
PDZ domain-mediated interactions of G protein-coupled receptors with postsynaptic density protein 95: quantitative characterization of interactionsThor C Møller, Volker F Wirth, Nina I Roberts, et al.
Journal of the American Chemical Society|December 2, 2011
Side-chain interactions form late and cooperatively in the binding reaction between disordered peptides and PDZ domainsS Raza Haq, Celestine N Chi, Anders Bach, et al.
Journal of Medicinal Chemistry|August 15, 2019
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular ActivityKim T Tran, Jakob S Pallesen, Sara M Ø Solbak, et al.
Organic & Biomolecular Chemistry|July 30, 2010
Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1Anders Bach, Nicolai Stuhr-Hansen, Thor S Thorsen, et al.
Journal of Medicinal Chemistry|October 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 InhibitorsYuting Qin, Cecilie Poulsen, Dilip Narayanan, et al.
Pageof 8